le 24 septembre/September 2019

	The common shares of InnoCan Pharma Corporation have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;<a href="https://thecse.com/en/listings/life-sciences/innocan-pharma-corporation">www.thecse.com</a>&nbsp;on the trading date.

	The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

	________________________

	Les actions ordinaires de InnoCan Pharma Corporation ont été approuvées à la cote du CSE.

	Les documents de cotation et d'information seront disponibles sur&nbsp;<a href="https://thecse.com/fr/inscriptions/sciences-biologiques/innocan-pharma-corporation">www.thecse.com</a>&nbsp;à la date de négociation.

	Les activités de la Société peuvent être décrites comme trois segments d'exploitation distincts liés à l'incorporation dans les produits de la CDB dans leur formulation : (i) la recherche, le développement, le marketing, la distribution et la vente de produits pharmaceutiques de gré à gré de marque InnoCan produits; ii) la recherche et le développement de produits non pharmaceutiques pour des tiers en échange de frais et/ou de redevances; et (iii) la recherche et le développement d'hydrogels contenant des liposomes destinés à l'octroi de licences ou à la vente à des sociétés pharmaceutiques tierces pour la fabrication, la distribution et la vente.

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	
<table border="1" cellpadding="1" cellspacing="1" >
<tbody >
<tr >
<td >
				Issuer/Émetteur:</td>
<td >
				InnoCan Pharma Corporation</td>
</tr>
<tr >
<td >
				Security Type/Titre:</td>
<td >
				Common&nbsp;Shares/Actions&nbsp;ordinaires</td>
</tr>
<tr >
<td >
				Symbol(s)/Symbole(s):</td>
<td >
				INNO</td>
</tr>
<tr >
<td >
				Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:</td>
<td >
				143 866 169</td>
</tr>
<tr >
<td >
				Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:</td>
<td >
				22 666 583</td>
</tr>
<tr >
<td >
				CSE Sector/Catégorie:</td>
<td >
				Life Sciences/Sciences biologiques</td>
</tr>
<tr >
<td >
				CUSIP:</td>
<td >
				45783P 10 2</td>
</tr>
<tr >
<td >
				ISIN:</td>
<td >
				CA 45783P 10 2 7</td>
</tr>
<tr >
<td >
				Boardlot/Quotité:</td>
<td >
				500</td>
</tr>
<tr>
<td >
				IPO Price/Prix:</td>
<td >
				$0.18/0,18 $</td>
</tr>
<tr>
<td >
				Agent:</td>
<td >
				Leede Jones Gable Inc.</td>
</tr>
<tr >
<td >
				Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:</td>
<td >
				CDN$/$CDN</td>
</tr>
<tr>
<td >
				Listing Date/Date de l’inscription:</td>
<td >
				le 24 septembre/September 2019</td>
</tr>
<tr >
<td >
				Trading Date/Date de&nbsp;negociation:</td>
<td >
				le 25 septembre/September 2019</td>
</tr>
<tr >
<td >
				Other Exchanges/Autres&nbsp;marches:</td>
<td >
				N/A</td>
</tr>
<tr >
<td >
				Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:</td>
<td >
				le 31 octobre/October</td>
</tr>
<tr >
<td >
				Transfer Agent/Agent des&nbsp;transferts:</td>
<td >
				Odyssey Trust Company</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for INNO. Please email:&nbsp;<a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions&nbsp;or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour&nbsp;toute&nbsp;question, pour&nbsp;obtenir&nbsp;de&nbsp;l’information&nbsp;supplémentaire&nbsp;veuillez&nbsp;communiquer&nbsp;avec&nbsp;le service des inscriptions au 416 367-7340 ou par&nbsp;courriel&nbsp;à&nbsp;l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

InnoCan Pharma Corporation

2019-0927 – New Listing - InnoCan Pharma Corporation (INNO)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.